- •Preface
- •Contents
- •Pattern Approach for Lung Imaging
- •1: Nodule
- •Solitary Pulmonary Nodule (SPN), Solid
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Lung Cancer (Solid Adenocarcinoma)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Carcinoid or Atypical Carcinoid
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •BALT Lymphoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Tuberculoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Hamartoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Sclerosing Hemangioma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Ground-Glass Opacity Nodule
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Atypical Adenomatous Hyperplasia (AAH)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Adenocarcinoma in Situ (AIS)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Minimally Invasive Adenocarcinoma (MIA)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •2: Mass
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Sarcoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Progressive Massive Fibrosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Actinomycosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •3: Consolidation
- •Lobar Consolidation
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Lobar Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Invasive Mucinous Adenocarcinoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Infarction
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Patchy and Nodular Consolidation
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Airway-Invasive Pulmonary Aspergillosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Cryptococcosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •IgG4-Related Lung Disease
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lymphomatoid Granulomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •4: Beaded Septum Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •References
- •5: Comet Tail Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Rounded Atelectasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •6: CT Halo Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Angioinvasive Pulmonary Aspergillosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Metastatic Hemorrhagic Tumors
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Endometriosis with Catamenial Hemorrhage
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •7: Galaxy Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Galaxy Sign in Pulmonary Tuberculosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •8: Reversed Halo Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Mucormycosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lymphomatoid Granulomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •9: Tree-in-Bud Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Aspiration Bronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Foreign-Body-Induced Pulmonary Vasculitis (Cellulose and Talc Granulomatosis)
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Bronchial Atresia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Bronchial Tuberculosis and Mucoid Impaction
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Foreign-Body Aspiration
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Allergic Bronchopulmonary Aspergillosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •11: Lobar Atelectasis Sign
- •Disease Causing the Sign
- •Distribution
- •Clinical Considerations
- •Right Upper Lobar Atelectasis
- •Left Upper Lobar Atelectasis
- •Right Middle Lobar Atelectasis
- •Lower Lobar Atelectasis
- •References
- •Cavity
- •Diseases Causing the Cavity
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Langerhans Cell Histiocytosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Septic Pulmonary Embolism
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Cavitary Pulmonary Tuberculosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Paragonimiasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Cyst
- •Diseases Causing the Cyst
- •Distribution
- •Clinical Considerations
- •Blebs and Bullae
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Sequestration
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Intrapulmonary Bronchogenic Cyst
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Traumatic Lung Cysts
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •References
- •Mosaic Attenuation
- •Diseases Causing the Mosaic Attenuation Pattern
- •Distribution
- •Clinical Considerations
- •Cystic Fibrosis
- •Pathology and Pathogenesis
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Constrictive Bronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Chronic Pulmonary Thromboembolism
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Idiopathic Pulmonary Arterial Hypertension
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Airway Disease (Bronchiectasis and Bronchiolectasis)
- •Distribution
- •Clinical Considerations
- •Swyer-James-MacLeod Syndrome
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Dyskinetic Cilia Syndrome
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •14: Air-Crescent Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Aspergilloma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Rasmussen’s Aneurysm
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •15: Signet Ring Sign
- •Diseases Causing the Sign
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •16: Interlobular Septal Thickening
- •Smooth Septal Thickening
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Edema
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Niemann–Pick Disease
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •Nodular Septal Thickening
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Lymphangitic Carcinomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT-Pathology Comparisons
- •Patient Prognosis
- •References
- •17: Honeycombing
- •Honeycombing with Subpleural or Basal Predominance
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Asbestosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Honeycombing with Upper Lung Zone Predominance
- •Diseases Causing the Pattern and Distribution
- •Distribution
- •Clinical Considerations
- •Idiopathic Familial Pulmonary Fibrosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Chronic Hypersensitivity Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •End-stage Fibrotic Pulmonary Sarcoidosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •18: Small Nodules
- •Small Nodules with Centrilobular Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Mycoplasma Pneumoniae Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diffuse Panbronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Follicular Bronchiolitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Tumor Embolism
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pneumoconiosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Sarcoidosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Alveoloseptal Amyloidosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Small Nodules with Random (Miliary) Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Miliary Tuberculosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Miliary Metastasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •19: Multiple Nodular or Mass(-like) Pattern
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pulmonary Metastasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Lymphoma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Amyloidomas
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •ANCA-Associated Granulomatous Vasculitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Ground-Glass Opacity with Reticulation and Fibrosis
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Ground-Glass Opacity with Reticulation, but without Fibrosis (Crazy-Paving Appearance)
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pneumocystis jirovecii Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lipoid Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pulmonary Alveolar Proteinosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Mucinous Adenocarcinoma or Adenocarcinoma in Situ, Diffuse Form
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Desquamative Interstitial Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Ground-Glass Opacity without Reticulation, with Small Nodules
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Subacute Hypersensitivity Pneumonitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Cytomegalovirus Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diffuse Alveolar Hemorrhage
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Ground-Glass Opacity without Reticulation, Diffuse Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Acute Hypersensitivity Pneumonitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Acute Eosinophilic Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •22: Consolidation
- •Consolidation with Subpleural or Patchy Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Cryptogenic Organizing Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Chronic Eosinophilic Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Churg–Strauss Syndrome
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Radiation Pneumonitis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Consolidation with Diffuse Distribution
- •Diseases Causing the Pattern
- •Distribution
- •Clinical Considerations
- •Viral Pneumonias
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Acute Interstitial Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Diffuse Alveolar Hemorrhage
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •23: Decreased Opacity with Cystic Walls
- •Cavities
- •Diseases Causing Cavities
- •Distribution
- •Clinical Considerations
- •Rheumatoid Lung Nodules
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Cavitary Metastasis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Cysts
- •Diseases Causing Multiple Cysts
- •Distribution
- •Clinical Considerations
- •Lymphangioleiomyomatosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Lymphocytic Interstitial Pneumonia
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •Emphysema
- •Distribution
- •Clinical Considerations
- •Centrilobular Emphysema
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •Patient Prognosis
- •Paraseptal Emphysema
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •Patient Prognosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •Patient Prognosis
- •References
- •24: Decreased Opacity without Cystic Walls
- •Mosaic Attenuation, Vascular
- •Distribution
- •Clinical Considerations
- •Airway Diseases Causing Mosaic Attenuation
- •Distribution
- •Clinical Considerations
- •Asthma
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •Distribution
- •Clinical Considerations
- •Cystic Fibrosis
- •Pathology and Pathogenesis
- •Symptoms and Signs
- •CT Findings
- •CT–Pathology Comparisons
- •Patient Prognosis
- •References
- •26: Pneumonia
- •Lobar Pneumonia
- •Bronchopneumonia
- •Interstitial Pneumonia
- •27: Drug-Induced Lung Disease
- •Interstitial Pneumonitis and Fibrosis
- •Eosinophilic Pneumonia
- •Cryptogenic Organizing Pneumonia
- •Diffuse Alveolar Damage
- •Hypersensitivity Pneumonia
- •References
- •Systemic Lupus Erythematosus (SLE)
- •Rheumatoid Arthritis (RA)
- •Progressive Systemic Sclerosis (PSS)
- •Sjögren’s Syndrome
- •Mixed Connective Tissue Disease
- •Ankylosing Spondylitis
- •References
Ground-Glass Opacity without Reticulation, with Small Nodules |
211 |
|
|
a |
b |
c |
d |
|
Ao
Br
Br Ao
Fig. 21.3 Subacute hypersensitivity pneumonitis in a 66-year-old woman. (a, b) Lung window images of thin-section (1.0-mm section thickness) CT scans obtained at levels of azygos arch (a) and distal bronchus intermedius (b), respectively, show the so-called head cheese sign with mixed inÞltrative (ground-glass opacity, arrows) and obstructive (mosaic attenuation, arrowheads) abnormalities. Ground-glass opacity is caused by lung inÞltration, whereas mosaic perfusion with decreased vessel sign is usually caused by small airway disease. (c)
High-magniÞcation (×100) photomicrograph of surgical biopsy specimen obtained from right upper lobe demonstrates bronchiolocentric granulomas (arrows) along with lymphocyte inÞltration (arrowheads) in peribronchiolar interstitium (alveolar walls). Ao arteriole, Br bronchiole. (d) High-magniÞcation photomicrograph (×200) discloses loosely formed granuloma (arrows) comprising epithelioid histiocytes and giant cells and surrounding lymphocyte cuff (arrowheads)
Ground-Glass Opacity without Reticulation, with Small Nodules
Definition
Ground-glass opacity (GGO) is caused by partial displacement of air in lung parenchyma. The opacity is caused by partial Þlling of airspaces, interstitial thickening (due to ßuid, cells, or Þbrosis), partial collapse of alveoli, or increased capillary blood volume. Without reticulation, the GGO areas usually represent active inßammatory or reversible disease state
(repetition see section ÒGround-Glass Opacity without Reticulation, Subpleural and Patchy DistributionÓ). In several diseases, the diffuse areas of GGO may contain small identiÞable poorly deÞned (GGO) nodules within the lesions or be associated with the nodules (Figs. 21.3, 21.4, and 21.5).
Diseases Causing the Pattern
Subacute hypersensitivity pneumonitis (HP) (Fig. 21.3), cytomegalovirus pneumonia (CMV pneumonia) (Fig. 21.4),
212 |
21 Ground-Glass Opacity without Reticulation |
|
|
a |
b |
c |
d |
Fig. 21.4 Cytomegalovirus pneumonia in a 28-year-old man with acute myeloid leukemia. (a, b) Lung window images of thin-section (1.0-mm section thickness) CT scans obtained at levels of main bronchi (a) and basal trunk (b), respectively, show patchy areas of ground-glass opacity in both lungs associated with branching small nodular structures (tree-in-bud sign, arrowheads) and somewhat larger nodules
(arrows) of acinus size. (c) High-magniÞcation (×100) photomicrograph of surgical lung biopsy specimen obtained from left lower lobe demonstrates organizing pneumonia (arrows) pattern with viral inclusion in epithelial cells consistent with cytomegalovirus pneumonia. (d) High-magniÞcation (×200) photomicrograph discloses viral inclusion bodies (arrows) in epithelial cells
and diffuse alveolar hemorrhage (DAH) particularly associated with pulmonary vasculitis (Fig. 21.5) may exhibit diffuse or extensive areas of GGO containing small poorly formed nodular (mainly GGO nodules) lesions [16].
Distribution
The areas of GGO in subacute HP are usually extensive, bilateral, and symmetric [17]. In some patients, they are patchy or asymmetric. Also in cytomegalovirus pneumonia, the GGO lesions show diffuse or patchy distribution without zonal predominance [18, 19]. The lesions in DAH are diffuse in the upper and lower lobes in approximately 75 % of patients or are localized in the lower part of the lungs in 25 % of patients. In both the cases, the apices and costophrenic angles are usually spared [20].
Clinical Considerations
Bird fancierÕs lung and farmerÕs lung are the two most leading cause of hypersensitivity pneumonitis [21]. CMV pneumonia is a common life-threatening complication seen in immunocompromised patients. It occurs most commonly after bone marrow and solid organ transplantation and in patients with AIDS [19]. The clinical syndrome in DAH includes hemoptysis, anemia, diffuse radiologic pulmonary opacity, and hypoxemic respiratory failure. The most common underlying histology of DAH is of a small vessel vasculitis known as pulmonary capillaritis, usually seen with seropositive systemic vasculitis, or a connective tissue disorder (bland pulmonary hemorrhage), and diffuse alveolar damage due to a number of injuries including, drugs, coagulation disorders, and infection [22] .
